Breast Cancer Trials
What happens when a drug is proving to be very effective in a trial?
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:04:49
- More information
Informações:
Synopsis
Associate Professor Nicholas Wilcken was the Study Chair of the HERA clinical trial which tested the drug Herceptin and delivered a major breakthrough for women with HER2 positive breast cancer. In this podcast, Associate Professor Wilcken discusses what happens when a drug is proven effective in a clinical trial. Find out more: www.breastcancertrials.org.au
